BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31147233)

  • 41. Enhanced Masses on Contrast-Enhanced Breast: Differentiation Using a Combination of Dynamic Contrast-Enhanced MRI and Quantitative Evaluation with Synthetic MRI.
    Matsuda M; Tsuda T; Ebihara R; Toshimori W; Takeda S; Okada K; Nakasuka K; Shiraishi Y; Suekuni H; Kamei Y; Kurata M; Kitazawa R; Mochizuki T; Kido T
    J Magn Reson Imaging; 2021 Feb; 53(2):381-391. PubMed ID: 32914921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics.
    Partridge SC; Rahbar H; Murthy R; Chai X; Kurland BF; DeMartini WB; Lehman CD
    Magn Reson Med; 2011 Jun; 65(6):1759-67. PubMed ID: 21254208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
    Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
    Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abbreviated screening protocol for breast MRI: a feasibility study.
    Grimm LJ; Soo MS; Yoon S; Kim C; Ghate SV; Johnson KS
    Acad Radiol; 2015 Sep; 22(9):1157-62. PubMed ID: 26152500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.
    Lee SJ; Ko KH; Jung HK; Koh JE; Park AY
    Eur J Radiol; 2020 Mar; 124():108841. PubMed ID: 31981877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.
    Dalmiş MU; Gubern-Mérida A; Vreemann S; Bult P; Karssemeijer N; Mann R; Teuwen J
    Invest Radiol; 2019 Jun; 54(6):325-332. PubMed ID: 30652985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies.
    Pötsch N; Dietzel M; Kapetas P; Clauser P; Pinker K; Ellmann S; Uder M; Helbich T; Baltzer PAT
    Eur Radiol; 2021 Aug; 31(8):5866-5876. PubMed ID: 33744990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.
    El Khouli RH; Macura KJ; Jacobs MA; Khalil TH; Kamel IR; Dwyer A; Bluemke DA
    AJR Am J Roentgenol; 2009 Oct; 193(4):W295-300. PubMed ID: 19770298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Artificial Intelligence Applied to Breast MRI for Improved Diagnosis.
    Jiang Y; Edwards AV; Newstead GM
    Radiology; 2021 Jan; 298(1):38-46. PubMed ID: 33078996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI.
    Wang S; Delproposto Z; Wang H; Ding X; Ji C; Wang B; Xu M
    PLoS One; 2013; 8(7):e67731. PubMed ID: 23844077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood Oxygenation Level Dependent Magnetic Resonance Imaging (MRI), Dynamic Contrast Enhanced MRI, and Diffusion Weighted MRI for Benign and Malignant Breast Cancer Discrimination: A Preliminary Experience.
    Fusco R; Granata V; Mattace Raso M; Vallone P; De Rosa AP; Siani C; Di Bonito M; Petrillo A; Sansone M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions.
    Mori N; Pineda FD; Tsuchiya K; Mugikura S; Takahashi S; Karczmar GS; Abe H
    AJR Am J Roentgenol; 2018 Oct; 211(4):933-939. PubMed ID: 30063374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast.
    Ao F; Yan Y; Zhang ZL; Li S; Li WJ; Chen GB
    Acta Radiol; 2022 Jul; 63(7):891-900. PubMed ID: 34134527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing ultrafast dynamic contrast-enhanced MRI scan duration in the differentiation of benign and malignant breast lesions.
    Cao Y; Huang Y; Chen X; Wang W; Chen H; Yin T; Nickel D; Li C; Shao J; Zhang S; Wang X; Zhang J
    Insights Imaging; 2024 May; 15(1):112. PubMed ID: 38713334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffusion kurtosis imaging does not improve differentiation performance of breast lesions in a short clinical protocol.
    Palm T; Wenkel E; Ohlmeyer S; Janka R; Uder M; Weiland E; Bickelhaupt S; Ladd ME; Zaitsev M; Hensel B; Laun FB
    Magn Reson Imaging; 2019 Nov; 63():205-216. PubMed ID: 31425816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.
    Liu C; Wang K; Chan Q; Liu Z; Zhang J; He H; Zhang S; Liang C
    Eur Radiol; 2016 Nov; 26(11):3888-3898. PubMed ID: 26863896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence.
    Milon A; Vande Perre S; Poujol J; Trop I; Kermarrec E; Bekhouche A; Thomassin-Naggara I
    Eur J Radiol; 2019 Aug; 117():199-208. PubMed ID: 31307648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Difference of DCE-MRI Parameters at Different Time Points and Their Predictive Value for Axillary Lymph Node Metastasis of Breast Cancer.
    Ya G; Wen F; Xing-Ru L; Zhuan-Zhuan G; Jun-Qiang L
    Acad Radiol; 2022 Jan; 29 Suppl 1():S79-S86. PubMed ID: 33504446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.